EU

Indemnity cover to become a statutory requirement

1 Mar 13 | 14.22 | England EU Northern Ireland Scotland Wales

New legislation is to be introduced that will put a statutory requirement on pharmacists to hold insurance...
more >
What are university students’ views on the self-prescribing of “smart drugs”?

19 Feb 13 | 17.05 | England EU International Northern Ireland Scotland Wales

Margit Anne Petersen, Emily Laing and Janine M. Traulsen discuss the results of a small pilot study on students’ experience and social understandings of taking smart drugs more >
France tasks EMA on contraceptive pill

1 Feb 13 | 13.50 | EU

France has suspended the marketing authorisation of Diane 35 (cytoterone acetate and ethinyestradiol; Bayer)...
more >
Formula used by NICE is flawed and should be abandoned, say researchers

28 Jan 13 | 17.09 | EU

The formula used by the National Institute for Health and Clinical Excellence to make decisions...
more >
EMA suspends marketing authorisation for Tredaptive

21 Jan 13 | 15.14 | EU

The marketing authorisation for Tredaptive (nicotinic acid and laropiprant) has been suspended by the European Medicines Agency...
more >
Zolpidem dose should be halved, says US regulator

18 Jan 13 | 13.40 | EU International

Recommended doses for zolpidem should be lowered because the drug can impair activities such as driving the day after use... more >
European groups demand government commitment

15 Jan 13 | 12.50 | EU

Governments across Europe must enable pharmacists to increase their role in optimising patients’ use of medicines...
more >
Celesio sets out plans for European network of pharmacies

8 Jan 13 | 15.25 | EU

Lloydspharmacy’s parent company Celesio plans to establish a European network of pharmacies...
more >
New topical treatment launched for actinic keratosis

4 Jan 13 | 16.22 | EU

Ingenol mebutate, a new drug for the topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis...
more >
Safety of Tredaptive under review by EMA

27 Dec 12 | 11.11 | EU

The safety and efficacy of nicotinic acid plus laropiprant (Tredaptive; Merck Sharp & Dohme), used to treat adults with dyslipidaemia in combination with a statin, is being reviewed... more >